Showing results (191-200 of 322) with videos related to
Sort By:
Pageof 33
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 12, 2026
Transforming endometrial cancer diagnosis: the case for molecular triage in abnormal uterine and post-menopausal bleedingAdeola Olaitan, Nora Pashayan, John Butler, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 17, 2020
LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trialAnnette Hasenburg, Jalid Sehouli, Bjoern Lampe, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 30, 2020
Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 studyRudiger Klapdor, Peter Hillemanns, Linn Wölber, et al.Geburtshilfe Und Frauenheilkunde|June 25, 2026
Statement by the Uterus Commission of the Arbeitsgemeinschaft Gynäkologische Onkologie [German Gynecological Oncology Group] (AGO) on the ESGO-ESTRO-ESP Guideline 2025Beyhan Ataseven, Marco Battista, Matthias W Beckmann, et al.Journal for Immunotherapy of Cancer|January 8, 2025
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a studyPeter Hillemanns, Michal Zikan, Frédéric Forget, et al.The Journal of Infectious Diseases|February 5, 2019
Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 VaccineNicolas Folschweiller, Ulrich Behre, Marc Dionne, et al.Med (New York, N.Y.)|October 10, 2025
Photodynamic therapy for high-grade squamous intraepithelial lesions: A randomized controlled trialFei Chen, Peter Hillemanns, Hongjie Ruan, et al.Die Rehabilitation|April 15, 2021
[Predictors of the Utilization and Waiting Period Before Starting an Oncological Rehabilitation after Breast Cancer]Dorothee Noeres, Stefanie Sperlich, Lena Röbbel, et al.Frontiers in Immunology|March 10, 2025
Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancerIvana Kutle, Robert Polten, Jan Lennart Stalp, et al.Frontiers in Immunology|January 9, 2025
Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancerIvana Kutle, Robert Polten, Jan Lennart Stalp, et al.Pageof 33